Eyenovia Inc (EYEN) Quote

I bought in today. Now I’ll sit and wait.

EYEN new 52 lo

EYEN new 52 lo

EYEN under $2

EYEN under $2

EYEN..........................................https://stockcharts.com/h-sc/ui?s=EYEN&p=W&b=5&g=0&id=p86431144783

EYEN.......................................https://stockcharts.com/h-sc/ui?s=EYEN&p=W&b=5&g=0&id=p86431144783

EYEN under $2

EYEN new 52 week low

EYEN new 52 week low

EYEN under $2

EYEN --
--Northland Adjusts Eyenovia's Price Target to $9 From $12, Maintains Outperform Rating
BY MT Newswires
— 9:31 AM ET 10/26/2021

EYEN now trading options!!!!

EYEN now trading options!!!!

Good NEWS

good Volume

https://eyenovia.com/about-2019/

* * $EYEN Video Chart 08-11-2020 * *

Link to Video - click here to watch the technical chart video

good Volume

OCGN - .62 orphan FDA approvals

Eyenovia and Arctic Vision Announce Exclusive Collaboration and License Agreement to Develop and Commercialize MicroPine and MicroLine in Greater China and South Korea
8:05 am ET August 11, 2020 (Globe Newswire) Print
Eyenovia Eligible to Receive up to a Total of $45.75 million in Upfront Payments and Development and Commercialization Milestones and Development Costs

Arctic Vision to Lead Expansion of Novel Approach to Treating Myopia and Presbyopia in Greater China and South Korea

Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose array print (MAP(TM)) therapeutics and Arctic Vision, a clinical stage biotech company focused on developing and commercializing innovative ophthalmology therapies in China and Asia, today announced that they have entered into an exclusive license agreement for Arctic Vision to develop and commercialize MicroPine for the treatment of progressive myopia and MicroLine for the treatment of presbyopia in Greater China (mainland China, Hong Kong, Macau and Taiwan) and South Korea.

Under the terms of the agreement, Eyenovia may receive up to a total of $45.75 million in upfront payments as well as additional payments, based on various development and regulatory milestones, including the initiation of clinical research and approvals in Greater China and South Korea, and development costs. In addition, Arctic Vision will purchase its supply of MicroPine and MicroLine from Eyenovia or, for such products not supplied by Eyenovia, pay Eyenovia a mid-single digit percentage royalty on net sales of such products, subject to certain adjustments. Eyenovia will pay a mid-double digit percentage of such payments, royalties, or net proceeds of such supply to its Asian licensee pursuant to the arrangement

next $10 stock soon

STRONG BUY

EYEN = MC $60 Million /NDA submission for BIG drug in Q3 / 2 more Drugs in Phase 3 including a potential Blockbuster /Undiscovered low float gem = A Potential 10+ Bagger Gem ..GLTA

anyone who sees the video of the kid using the machine will buy the stock.
So easy and simple to use-REVOLUTIONARY. Very impressive.

RALLLYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYY

looks like next breakout about to start

Load up before she takes off again

STRONG BUY this pure undiscovered Goldmine

Down a lot today. I'd say related to ALDX (another "eyes" biotech) which is down about 32% following Top-Line results. It's a mistake to associate the faith of those 2 IMO. This is creating a great opportunity. Will go back over 4$ very soon and may never "look" back. This wild horse will suddenly run free at some point. Great MGT. Founder keeps on buying. Great innovation. First-in-class comes to mind.

4 years from now 300 dollar stock when myopia drug approved

UUUUUUUUUUUUUUUUUUUP again and still terrible undervalued

BOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOM

$20 stock trading at $3

mega potential here

could run fast

love it

Zacks raises stock to BUY today and there is nobody here. Wow.

olympus investments takes 70.000 share position

200k day, crazy trading swings. should be volume reversal, we shall see.

Company is a conduit for drug delivery for every topical eye care drug company in existence, and hence will be bought out.

Game of Rogues- 40 cent spread between bid and asked, no law in the Wild West.

The undiscovered country.
This is going to be the new application standard for all things eye.
One machine with multi-function use.
Enormous market. one of a kind tech with no competition, as they lead with multiple phase 3 trials, and small cap equals grand slam home run.